According to Laboratorios Farmaceuticos Rovi's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.17202. At the end of 2023 the company had a P/S ratio of 3.83.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.83 | 67.59% |
2022 | 2.29 | -62.36% |
2021 | 6.08 | 14.86% |
2020 | 5.29 |